Phase 2 Trial Results (48 Weeks) The Phase 2 trial randomized 338 adults with obesity (BMI 30) or overweight with at least one weight-related condition to retatrutide or placebo for 48 weeks (Jastreboff et al., NEJM 2023)
do not combine prescription medications with research peptides without medical supervision
Instead, it should be kept separate and specifically declared to airport security
Theyre sold over the counter without a prescription (which makes them easily accessible) and you apply a new patch to clean, dry skin each day, usually rotating between areas like your upper arm, thigh, or abdomen
The disadvantage is that it can cause vomiting
MONDAY, March 2, 2026 (HealthDay News) Weight-loss drugs like Ozempic and Zepbound might also help people manage migraines, a new study says